Literature DB >> 23483462

Abnormal splenic artery diameter/hepatic artery diameter ratio in cirrhosis-induced portal hypertension.

Dao-Bing Zeng1, Chuan-Zhou Dai, Shi-Chun Lu, Ning He, Wei Wang, Hong-Jun Li.   

Abstract

AIM: To determine an optimal cutoff value for abnormal splenic artery diameter/proper hepatic artery diameter (S/P) ratio in cirrhosis-induced portal hypertension.
METHODS: Patients with cirrhosis and portal hypertension (n = 770) and healthy volunteers (n = 31) underwent volumetric computed tomography three-dimensional vascular reconstruction to measure the internal diameters of the splenic artery and proper hepatic artery to calculate the S/P ratio. The cutoff value for abnormal S/P ratio was determined using receiver operating characteristic curve analysis, and the prevalence of abnormal S/P ratio and associations between abnormal S/P ratio and major complications of portal hypertension were studied using logistic regression.
RESULTS: The receiver operating characteristic analysis showed that the cutoff points for abnormal splenic artery internal diameter and S/P ratio were > 5.19 mm and > 1.40, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value were 74.2%, 45.2%, 97.1%, and 6.6%, respectively. The prevalence of an abnormal S/P ratio in the patients with cirrhosis and portal hypertension was 83.4%. Patients with a higher S/P ratio had a lower risk of developing ascites [odds ratio (OR) = 0.708, 95%CI: 0.508-0.986, P = 0.041] and a higher risk of developing esophageal and gastric varices (OR = 1.483, 95%CI: 1.010-2.175, P = 0.044) and forming collateral circulation (OR = 1.518, 95%CI: 1.033-2.230, P = 0.034). After splenectomy, the portal venous pressure and maximum and mean portal venous flow velocities were reduced, while the flow rate and maximum and minimum flow velocities of the hepatic artery were increased (P < 0.05).
CONCLUSION: The prevalence of an abnormal S/P ratio is high in patients with cirrhosis and portal hypertension, and it can be used as an important marker of splanchnic hemodynamic disturbances.

Entities:  

Keywords:  Cirrhosis; Complications; Portal hypertension; Proper hepatic artery internal diameter; Splenectomy; Splenic artery internal diameter

Mesh:

Year:  2013        PMID: 23483462      PMCID: PMC3587487          DOI: 10.3748/wjg.v19.i8.1292

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  Portal hypertension: from bedside to bench.

Authors:  Roberto J Groszmann; Juan G Abraldes
Journal:  J Clin Gastroenterol       Date:  2005-04       Impact factor: 3.062

Review 2.  Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications.

Authors:  Felix Dahm; Panco Georgiev; Pierre-Alain Clavien
Journal:  Am J Transplant       Date:  2005-11       Impact factor: 8.086

3.  Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome.

Authors:  Anthony J Demetris; Dympna M Kelly; Bijan Eghtesad; Paulo Fontes; J Wallis Marsh; Kusum Tom; Heinke P Tan; Thomas Shaw-Stiffel; Linda Boig; Paula Novelli; Raymond Planinsic; John J Fung; Amadeo Marcos
Journal:  Am J Surg Pathol       Date:  2006-08       Impact factor: 6.394

4.  Successful treatment of small-for-size syndrome in adult-to-adult living-related liver transplantation: single center series.

Authors:  Salvatore Gruttadauria; Lucio Mandala'; Roberto Miraglia; Settimo Caruso; Marta Ida Minervini; Domenico Biondo; Riccardo Volpes; Giovanni Vizzini; J Wallis Marsh; Angelo Luca; Amadeo Marcos; Bruno Gridelli
Journal:  Clin Transplant       Date:  2007 Nov-Dec       Impact factor: 2.863

Review 5.  Hemodynamic alterations in liver cirrhosis.

Authors:  Giorgio La Villa; Paolo Gentilini
Journal:  Mol Aspects Med       Date:  2007-10-24

6.  Evolving experience with prevention and treatment of splenic artery syndrome after orthotopic liver transplantation.

Authors:  Martina T Mogl; Natascha C Nüssler; Sabine J Presser; Petr Podrabsky; Timm Denecke; Christian Grieser; Peter Neuhaus; Olaf Guckelberger
Journal:  Transpl Int       Date:  2010-02-18       Impact factor: 3.782

7.  Arteriographic studies of splenic and hepatic arteries in portal hypertension.

Authors:  H Yamauchi; Y Suda; K Yamamoto; T Sato
Journal:  Tohoku J Exp Med       Date:  1970-08       Impact factor: 1.848

8.  "Splenic artery steal syndrome" is a misnomer: the cause is portal hyperperfusion, not arterial siphon.

Authors:  Cristiano Quintini; Kenzo Hirose; Koji Hashimoto; Teresa Diago; Federico Aucejo; Bijan Eghtesad; David Vogt; Gregory Pierce; Mark Baker; Dympna Kelly; Charles M Miller
Journal:  Liver Transpl       Date:  2008-03       Impact factor: 5.799

9.  Multidetector computed tomography angiography in detection of active bleeding in renal and liver transplant recipients.

Authors:  I Kirbas; N U Tutar; F K Emiroglu; M Coskun; M Haberal
Journal:  Transplant Proc       Date:  2007-05       Impact factor: 1.066

10.  Noninvasive evaluation of portal hypertension: emerging tools and techniques.

Authors:  V K Snowdon; N Guha; J A Fallowfield
Journal:  Int J Hepatol       Date:  2012-06-07
View more
  6 in total

1.  New strategies for prevention and treatment of splenic artery steal syndrome after liver transplantation.

Authors:  Ji-Yong Song; Bing-Yi Shi; Zhi-Dong Zhu; De-Hua Zheng; Gang Li; Li-Kui Feng; Lin Zhou; Tian-Tian Wu; Guo-Sheng Du
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

2.  A case of abnormally dilated and tortuous arc of Buhler and pancreaticoduodenal arteries in the absence of celiac trunk stenosis.

Authors:  Sonali Rathod; Riley Kolus; Byungchan Kim; Sarika Gurnani; Andy Kim; Erin Kim; Faisal Tan; Isabelle Van Roy; Elizabeth Whitney; Maryann MacNeil; Jonathan J Wisco
Journal:  Surg Radiol Anat       Date:  2022-09-17       Impact factor: 1.354

3.  Characterization of uncommon portosystemic collateral circulations in patients with hepatic cirrhosis.

Authors:  Qin Wu; Lijun Shen; Jindong Chu; Xuemei Ma; Bo Jin; Fanping Meng; Jinpin Chen; Yanling Wang; Libing Wu; Jun Han; Wenhui Zhang; Wei Ma; Huaming Wang; Hanwei Li
Journal:  Oncol Lett       Date:  2014-10-22       Impact factor: 2.967

4.  The Effect of Splenectomy on the Reversal of Cirrhosis: a Prospective Study.

Authors:  Dao-Bing Zeng; Liang Di; Rui-Chi Zhang; Qing-Liang Guo; Bin-Wei Duan; Cui-Yu Jia; Feng Chen; Dong-Dong Lin; Yun-Jin Zang; Shi-Chun Lu
Journal:  Gastroenterol Res Pract       Date:  2019-04-08       Impact factor: 2.260

5.  Splenectomy with Portoazygous Disconnection for Correction of Systemic Hemodynamic Disorders in Hepatic Cirrhosis Patients with Portal Hypertension: A Prospective Single-Center Cohort Study.

Authors:  Dao-Bing Zeng; Liang Di; Qing-Liang Guo; Jing Ding; Xiao-Fei Zhao; Shi-Chun Lu
Journal:  Can J Gastroenterol Hepatol       Date:  2020-12-21

6.  Association Between Changes in Splanchnic Hemodynamics and Risk Factors of Portal Venous System Thrombosis After Splenectomy with Periesophagogastric Devascularization.

Authors:  Long Huang; Qingsheng Yu; Jiajia Wang
Journal:  Med Sci Monit       Date:  2018-06-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.